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ABSTRACT 
 Wilson’s disease is characterized by long-term hepatic accumulation of copper 
leading to liver disease with reduction of S-adenosylmethionine synthesis. However, the 
initial changes in this pathway remain unknown and constitute the objective of the 
present study. Using the Long Evans Cinnamon rat model early alterations in the 
mRNA and protein levels, as well as in the activities of several enzymes of the 
methionine cycle were detected. Noteworthy, the main change was a redox mediated 
80% decrease in the mRNA levels of the methionine adenosyltransferase regulatory 
subunit as compared to the control group. Moreover, changes in S-adenosylmethionine, 
S-adenosylhomocysteine, methionine and glutathione levels were also observed. In 
addition, in vitro experiments show that copper affects the activity and folding of 
methionine adenosyltransferase catalytic subunits. Taken together, these observations 
indicate that early copper accumulation alters methionine metabolism with a pattern 
distinct from that described previously for other liver diseases.  
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INTRODUCTION 
 The liver exerts a central role in methionine metabolism [1] and copper 
homeostasis [2]. This metal ion appears bound to glutathione, amino acids, transport or 
storage proteins and as an essential cofactor to many enzymes [3]. Transport of copper 
is mediated by several proteins, including: ATP7A, CTR1 and ATP7B [3]. ATP7A 
controls passage of copper from the intestinal cells into the portal circulation, and its 
absence causes Menkes’ disease [4]. The CTR1 transporter takes copper from the 
carriers in the portal circulation into the hepatocyte [5], where the metal is rapidly 
routed to copper metallochaperones of the cytosol, mitochondria and secretory 
pathways [3,6]. On the other hand, ATP7B is involved in copper transference to the bile 
(1.5 mg/day in humans), the major route for excretion, and a critical process in 
maintaining the hepatic concentration of the metal [2]. For this purpose, copper-loaded 
ATP7B translocates from the trans-Golgi network to the vesicular compartment. Either 
the absence or a reduced activity of this transporter leads to hepatic copper 
accumulation that results in Wilson’s disease [7].  
 Liver is also the site for early copper accumulation in pathological processes. 
Normal copper levels (10-100 µM) [3] can increase up to 30-50 times at early stages of 
Wilson’s disease with little clinical manifestations [7]. Long Evans Cinnamon rats 
(LEC) have been extensively used as a model for studies of this pathology [8, 9] due to 
the similarities observed in clinical and biochemical features. The presence of genetic 
defects affecting the ATP7B gene are the cause of the disease in either humans or 
animal models, but the anomalies detected are not identical. LEC rats present a 900 bp 
deletion in the coding region of the ATP7B gene [10], whereas the most frequently 
reported mutation in Wilson’s disease patients is the H1069Q substitution [7]. LEC rats 
suffer acute hepatitis at 8-12 weeks of age and a large incidence of death between 17-20 
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weeks. Survivors develop cirrhosis and are highly susceptible to hepatocellular 
carcinoma (HCC), two manifestations of hepatic disease in which impairment of 
methionine metabolism has been reported in animal models and human samples of other 
etiologies [11-13].  
 Three MAT genes exist in mammals, MAT1A, MAT2A and MAT2B. Catalytic 
subunits, MATα1 and MATα2, are codified by MAT1A and MAT2A, respectively, 
whereas the product of the MAT2B gene is the regulatory β subunit [1]. MATα1 
subunits associate to render homodimers (MAT III) and homotetramers (MAT I) that 
differ in their affinity for methionine, and constitute the main hepatic isoenzymes under 
normal conditions. On the other hand, MATα2 and β subunits form hetero-oligomers 
that constitute the main fetal and cancer related isoenzyme (MAT II). Impairment of the 
methionine cycle during pathologic processes includes decreases in total MAT activity, 
switches in the levels of MAT mRNAs [14], and changes in the ratio of the homo-
oligomers MAT I and III [15]. Moreover, MAT1A knockout mice show reduced S-
adenosylmethionine (AdoMet) levels and develop HCC spontaneously [16], whereas 
AdoMet treatment in animal models of liver injury has been reported be 
hepatoprotective [17]. These data suggest the existence of a direct link between several 
hepatic pathological processes and methionine metabolism. In addition, another enzyme 
of this pathway, S-adenosylhomocysteine hydrolase (SAHH) has been shown to bind 
(Kd ∼ 10-11 M) and to be inactivated by copper (Ki 14 nM) [18]. In spite of all these 
data, potential alterations in the methionine cycle due to copper accumulation have not 
been explored, except for a measurement of MAT activity and AdoMet levels in LEC 
rats at late phases of the disease (29 and 42 weeks) [19]. Thus, the purpose of this work 
was to get insight into the changes in the hepatic methionine cycle at early stages of 
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copper accumulation to decipher the events involved in the development of this 
pathology.  
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MATERIALS AND METHODS 
 2.1 Animals and tissue extraction. Long Evans (LE) and Long Evans Cinnamon 
(LEC) rats 9 weeks old were purchased through Charles River Laboratories España 
(Barcelona, Spain). All animals were treated according to the Guidelines for Animal 
Experimentation of the CSIC and the European Union. Tissues were extracted 
immediately after animal death, placed on liquid nitrogen and stored at -80ºC.  
 2.2 Histology. Rat liver portions were embedded in paraffin after formaldehyde 
fixation and dehydration. Sections (10 microns) were prepared and morphological 
analysis carried out after paraffin elimination and rehydration followed by hematoxilin-
eosin staining. The method of Jain et al. [20] with slight modifications was used for 
identification of copper deposits. Briefly, sections were stained with a mixture of 0.1% 
rubeanic acid in ethanol 1:20 (v/v) and 10% sodium acetate overnight at 37ºC, cleared 
in ethanol and xylene. In addition, iron deposits were visualized by Perls’ stain [21]. 
Briefly, sections were immersed in a mixture of 10% potassium ferrocyanide and 2% 
hydrochloric acid 1:1 (v/v) for 10 min, cleared with water and counterstained with 
nuclear red. Finally, sections were dehydrated and coverslip mounted with Eukit (Sigma 
Chemical Co, St. Louis) for observation with a Leica DMR Microscope equipped with a 
Leica DFC 320 video camera connected to a Fujitsu Celeron computer. Standard digital 
image capture was obtained using an Adobe Photoshop CS 8.0 image capture card. 
 2.3 Cell treatments. Hepatoma H35 cells at 80% confluence were treated with 1 
mM CuSO4, 5 mM N-acetylcysteine (NAC), 10 µM neocuproine or 1 mM buthionine 
sulfoximine (BSO) before RNA extraction. Combination of the different treatments was 
performed by addition of neocuproine 2 hours before copper addition, whereas NAC 
and BSO were included 8 hours before the metal. Copper incubations were performed 
for 24 hours. 
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 2.4 RNA extraction and quantitative RT-PCR. Total RNA was isolated using the 
Trizol method (Sigma Chemical Co, St. Louis) and quality and quantity determined 
spectrometrically and by gel electrophoresis. Gene specific primers were designed using 
the program Primer Express 3.0 (Applied Biosystems, Foster City) with Tm values 
between 58-60ºC (Table 1 of supplementary material). Expression of the different 
mRNAs of our interest was evaluated using the ABI 7900HT Real-Time PCR system 
(Applied Biosystems). Reverse transcription was done using 1.25 µg of total RNA and 
the High Capacity Archive kit (Applied Biosystems). cDNAs (10 ng) were amplified in 
triplicate using appropriate primer concentrations (Table 1 of supplementary material) 
and Power SYBR Green PCR Master Mix (Applied Biosystems) in a total reaction 
volume of 10 µl at the sequencing facilities of the Instituto de Investigaciones 
Biomédicas Alberto Sols (CSIC-UAM). The thermal protocol included: i) 10 min 
denaturation at 95ºC; and ii) 15 s denaturation at 95ºC followed by 1 min extension at 
60ºC for 40 cycles. Fluorescent signals were collected after each extension step, and the 
curves analyzed by the SDS 2.2.2 software. The specificity of the amplification was 
determined after the last cycle of the PCR reaction by dissociation curve analysis. 
Relative expression ratios were normalized to the geometric mean of the 18S gene used 
as a control. Experimental efficiencies were calculated for each transcript and used to 
obtain the fold changes according to Pfaffl et al. [22].  
 2.5 Preparation of cytosolic fractions and activity measurements. Cytosolic 
samples were prepared as described previously [23] and used to determine MAT 
activity with reaction mixtures containing either 5 mM, 60 µM or 60 µM methionine 
plus 10% (v/v) DMSO [23]. The same cytosols were used to determine BHMT activity 
using 75 µl of the sample for 2 hours at 37ºC as described previously [24]. Samples 
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from column fractions (100 µl) were analyzed for MAT activity using 5 mM 
methionine. 
 2.6 Western blot and Dot blot. Cytosolic samples (25 µg) were used for 
immunoblotting [23] with the following antibodies: i) polyclonal anti-MAT antiserum 
(1:10000 v/v) [25]; ii) polyclonal anti-BHMT antiserum (1:20000 v/v)[26]; iii) anti-
SAHH antiserum (1:1000 v/v) kindly provided by Dr. D. Kloor [27]; and iv) 
monoclonal anti α-tubulin antibody (Sigma Chemical Co, St. Louis, 1:500 v/v). Blots 
were subjected to densitometric scanning using ImageJ v. 1.37 
(http://rsb.info.nih.gov/ij/) and the values were normalized against the α-tubulin control. 
The lack of commercial antibodies against rat MAT2β and the failure of the anti-human 
counterpart to recognize the rat protein precluded the analysis of the regulatory subunit. 
Gel filtration column fractions (10 µl) were used for dot blot as previously described 
[28]. 
 2.7 Gel filtration chromatography. Cytosolic samples (100 µl) were loaded on a 
Superose 12/10 HR column (GE Healthcare España SA, Barcelona) equilibrated and 
eluted at 0.3 ml/min in 50 mM Tris/HCl pH 8, 10 mM MgSO4, 1 mM EDTA containing 
150 mM KCl. This buffer also included 250 µM CuSO4 for the analysis of copper 
effects on MAT subunit association. In all the cases 210 µl fractions were collected for 
activity measurements and dot-blot analyses. Molecular weight standards and their 
elution volume are indicated on the corresponding figure legends.  
 2.8 Analysis of the redox state of BHMT and MAT. Cytosolic samples (40 µg) 
isolated in the presence of 40 mM iodoacetamide as described by Cumming et al. [29] 
were loaded on 12% SDS-PAGE gels under non-reducing conditions. Lanes were 
excised and incubated with DTT and iodoacetamide before loading on the second 
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dimension 12% SDS-PAGE gel that was transferred to Immobilon membranes 
(Millipore Corporation, Bedford) and developed as described above. 
 2.9 MAT refolding and copper effects on activity and structure. Recombinant 
MATα1 and MATα2 subunits were DTT-refolded in the presence or absence of 250 
µM CuSO4 as previously described [30]. Copper effects on activity were analyzed using 
the DTT-refolded proteins (50 µg/ml). For this purpose, the DTT used for refolding was 
eliminated by dialysis and MAT activity measured in the presence of 0-1 mM CuSO4 
using reaction mixtures with or without DTT. Addition of copper was performed using 
50 mM Tris/HCl pH 8 or 50 mM Tris/HCl, 50 mM Glycine pH 8 buffers as carriers. 
Inhibition constants were calculated using GraphPad Prism v. 5.0 (GraphPad Software, 
San Diego). The effect of copper (250 µM) on oligomerization was analyzed by gel 
filtration chromatography and dot blot. 
 2.10 Analysis of metabolite levels. Quantification of glutathione reduced (GSH) 
and oxidized forms (GSSG), AdoMet, AdoHcy, methionine and Hcy was performed at 
OWL Genomics facilities (Derio, Vizcaya, Spain). Briefly, tissue samples were 
homogenized in 0.4 M perchloric acid and the supernatant used for determination of the 
GSH and GSSG levels. On the other hand, derivatization using 6-aminoquinolyl-N-
hydroxysuccinimidyl carbamate using the AccQ Tag Ultra derivatization kit (Waters, 
Milford) was performed for AdoMet, AdoHcy, Hcy and methionine measurements. 
Samples were analyzed at 50ºC using a BEH C18 column (Waters) and a gradient from 
0.05% formic acid:water (buffer A) to 0.05% formic acid: acetonitrile (buffer B) 
coupled to ESI detection. 
 2.11 Statistics. Data are expressed as mean ± SD, and Student’s t test for 
unpaired samples was applied for statistical analysis using GraphPad Prism v.5.0 
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(GraphPad Software, San Diego). Differences were considered significant when p 
<0.05.  
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RESULTS 
 Livers of 9 weeks old LE and LEC rats showed notable differences in size. In 
fact, the liver weight was 12.09 ± 0.34 g and 5.64 ± 0.59 g for LE and LEC rats, 
respectively. Histological analysis of the samples revealed hepatic accumulation of 
copper and iron in LEC rats, but no signs of hepatitis were visible (Figure 1). Thus, 
LEC rats show the early symptoms typically described for the presence of the ATP7B 
mutation. 
 The presence of alterations in the methionine cycle was initially studied by real-
time PCR. Changes in mRNA levels for the different enzymes of this pathway were 
analyzed and normalized against the 18S mRNA. PCR amplification showed increases 
in BHMT and MAT2A transcripts, whereas reductions in the levels for MAT1A, 
MAT2B, MS and SAHH were concomitantly observed in the LEC group (Figure 2). 
The most prominent effect was an 80% decrease in MAT2B expression, whereas 
changes in MAT1A, MAT2A, MS and SAHH transcript levels ranged from 17-30% and 
the slight increase detected for the BHMT transcript was not significant. 
 We next studied if these changes in mRNA correlate with alterations at the 
protein level. For this purpose, western blots of the samples were carried out using the 
available anti-MAT I/III, anti-BHMT and anti-SAHH antibodies. The results showed 
∼30% reductions in the amount of MAT I/III and SAHH proteins in the LEC group, 
whereas no variation in BHMT protein levels was detected (Figure 3). These data were 
in good agreement with the changes observed in mRNA. 
 Alterations in the amount of protein could be reflected in enzyme activities, and 
hence in the levels of the different metabolites of this pathway. Measurements of the 
levels for AdoMet, AdoHcy, Hcy and methionine were carried out in samples of both 
animal groups (Table 1). The results in the LEC group indicate reductions in AdoHcy 
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levels and a tendency of AdoMet levels to decrease. In addition, no changes were 
observed in Hcy concentrations, although a significant increase in methionine levels 
was observed. Additionally, glutathione levels were also measured in these samples. 
The data indicate a ∼30% decrease in GSH and a tendency of GSSG concentrations to 
enhance. Thus, the net result is an apparent increase in the methylation index 
(AdoMet/AdoHcy) and a decrease in the GSH/GSSG ratio in the LEC group.  
 The low amount of tissue available forced a restriction of the analysis of 
enzymatic activities to those of BHMT and MAT that could be carried out with the 
same sample preparations. No changes in methionine synthesis by BHMT were 
detected, whereas alterations in MAT activity were observed in LEC rats (Table 2). 
Differences in methionine affinity, along with the DMSO stimulatory capacity for MAT 
III have been traditionally used to distinguish among MAT isoenzymes. Thus, we 
performed measurements of MAT activity at different methionine concentrations and in 
combination with DMSO. A 30 % reduction in total activity (MAT I + MAT II + MAT 
III) was detected at 5 mM methionine, whereas a 17% increase was observed when 
methionine was used at 60 µM (MAT I + MAT II). Moreover, DMSO stimulation of 
MAT III allowed detection of a 17% decrease in the activity of the dimer (Table 2). 
These results suggested an increase in the activity of MAT I and II at the expense of 
MAT III. However, through this type of measurements we cannot correlate the changes 
in activity with those in protein or mRNA levels, and thus we cannot distinguish 
whether the alterations are due solely to the alterations of the levels of each isoenzyme 
or if there is also an effect of copper on catalysis.  
 It is well known that MATα1 subunits associate into dimers (MAT III) and 
tetramers (MAT I), and that the ratio between these forms is displaced towards the 
dimer in liver diseases. Moreover, in many of these pathologies oxidative stress is 
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produced, a mechanism known to inhibit MAT I/III. Thus, the net changes in MAT 
activity can be due to several factors: i) alterations in expression of this type of catalytic 
subunit; ii) its preferred association into one or another oligomeric assembly; iii) 
inhibition through mechanisms such as oxidation; or iv) a combination of these factors. 
Since a decrease in expression was already proved and activity data suggested a 
reduction in MAT III content, we next studied the possibility of changes in the 
oligomeric state due to copper accumulation by gel filtration chromatography (Figure 
4). Activity profiles showed peaks corresponding to tetramers (∼200 kDa, MAT I and 
II) and dimers (∼110 kDa, MAT III) with higher activity levels for LE than for LEC 
rats. In addition, an increase in the activity of the tetramers could be observed in 
samples of the LEC group, although distinction between the contributions of MAT I and 
II was precluded due to coelution. In order to overcome this problem, we analyzed the 
fractions for the presence of MATα1 protein using the specific antibody (Figure 4). Dot 
blots revealed a consistent increase in MAT I content and a reduction in that of MAT III 
in livers of LEC rats. Dimer/tetramer ratios estimated by activity measurements were 
calculated to be 5.48 ± 1.31 and 4.13 ± 0.9 (p=0.263), and when calculated by protein 
levels values of 4.8 ± 2.92 and 3.87 ± 1.3 (p=0.247) were found for LE and LEC 
groups, respectively. These values are not significant probably due to the low precision 
of this method, but represent the tendency observed in all the animals in each group. 
Elution patterns for BHMT, a tetramer, were not modified between animal groups (data 
not shown), and serve as an internal control of sample manipulation. Thus, this type of 
analysis suggests that copper accumulation has an effect on MATα1 oligomerization. 
 Metals such as copper could exert their effects by direct binding to their target 
proteins or through their oxidation. As mentioned above MAT I/III is known to be 
highly susceptible to thiol oxidation, and such process leads to enzyme inactivation. 
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Since an alteration of the GSH/GSSG ratio in LEC rats was detected, the possibility of 
MAT I/III thiol oxidation was also explored using bidimensional gels under non- 
reducing/reducing conditions. The results revealed no changes in the mobility pattern 
for this protein between animal groups (data not shown), thus suggesting no redox 
modification detectable by this technique. A parallel analysis carried out for BHMT 
showed also no change in the oxidation state of this enzyme. 
 As the mixture of MAT isoenzymes present in liver samples precluded analysis 
of copper effects on individual forms, but suggested alterations in subunit 
oligomerization and activity, we performed several in vitro assays using recombinant 
MAT catalytic subunits. First, the possibility of a copper effect on folding was explored 
by performing refolding assays of MATα1 and MATα2 subunits in the presence or 
absence of copper sulfate using protocols previously developed in our laboratory. In 
both cases, the recovery of active protein was reduced when this cation was present, but 
no influence in the association state (tetramers and dimers) attained was observed (data 
not shown). Moreover, the specific activity of the DTT-Cu-refolded MAT I/III was 
slightly higher than that of the DTT-refolded protein (102.86 ± 14.16 vs. 91.81 ± 5.37 
nmol/min/mg; p=0.047), whereas a minimal difference was observed for MATα2 
(53.87 ± 0.59 vs. 52.19 ± 0.3 nmol/min/mg, p=0.012). Together these results suggest 
that copper could also affect the production of correctly folded protein. 
 Second, copper could also exert an effect on MAT activity. Thus, to analyze this 
point, the activity of the refolded MATα subunits was assayed in the presence of copper 
sulfate. Since copper in vivo appears bound to different types of carriers our assays were 
performed in the presence of Tris or Tris/Glycine. The effects observed were 
independent of the metal carrier of choice, but were influenced by the redox conditions 
in the assay (Figure 5). MATα2 was inhibited by copper in the presence of DTT with a 
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calculated IC50 of 748.2 ± 1.03 µM, whereas this IC50 value became 286.9 ± 1.24 µM in 
the absence of the reducing agent, thus decreasing 2.5-fold. On the other hand, the 
effects on MAT1α activity dramatically depended on the redox conditions in which the 
protein was present. A slight activation was observed with DTT, whereas in its absence 
inhibition was detected (IC50 39.04 ± 1.09 µM). These data indicated a higher 
susceptibility of MATα2 activity to copper action under reducing conditions, whereas 
under low reducing conditions MATα1 was inactivated at lower metal concentrations 
than MATα2. In addition, copper inhibition of both types of catalytic subunits 
correlated with the appearance of high-Mr complexes, suggesting changes at the 
structural level. All these in vitro data together confirm the possibility of copper acting 
on the catalytic activity of MAT isoenzymes, their susceptibility depending on the redox 
environment.  
 The remaining question concerns the elucidation of the mechanisms underlying 
the striking reduction in MAT2B mRNA levels. In order to clarify this point hepatoma 
H35 cells were treated with copper sulfate alone or in combination with an antioxidant 
(NAC), a copper chelator (neocuproine) or an inducer of oxidative stress (BSO) and 
MAT2B mRNA levels evaluated by real-time RT-PCR (Figure 6). The results confirm 
the strong reduction in MAT2B expression induced by copper (60%) and show 
increased expression under oxidative stress (40%). Copper effects could only be 
prevented by BSO, whereas NAC and neocuproine were ineffective, the combined 
treatment with neocuproine and copper inducing a large percentage of cell death. Thus, 
these data indicate a redox mechanism as responsible for MAT2B repression by the 
metal. 
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DISCUSSION 
 Alterations in liver methionine metabolism under pathological conditions have 
been known for more than 50 years [31,32]. The effects described include changes in 
expression, protein levels, enzyme activity and in some cases in the ratio of oligomeric 
isoforms [11-13,15,33]. A common fact for most of these pathologies is the 
development of oxidative stress, a condition known to regulate the activity of enzymes 
of the methionine cycle [34,35]. Efforts have been concentrated in the elucidation of the 
relationship between changes in this pathway and the development of cirrhosis and 
cancer [16,36,37], but scarce studies have been carried out for other disorders, such as 
Wilson’s disease. In fact, only one report describing a reduction in MAT activity and 
AdoMet levels at the late stages of the disease in LEC rats has been published [19]. 
Thus, the possibility of early changes in this pathway has not been explored, and hence, 
its potential alteration as an initial event in Wilson’s disease development ignored.  
 In the present work, we show that LEC rats in the early phase of copper 
accumulation already showed the typical reduction in liver size, as well as the copper 
and iron deposits previously described [8,38]. Changes in mRNA levels for enzymes of 
the methionine cycle were also detectable by real-time RT-PCR, these alterations being 
moderate for most of the proteins (Figure 7A). In fact, previous expression studies with 
ATP7B knockout mice (6 week old) reported weak effects on global amino acid 
metabolism [39]. In contrast, a large decrease in MAT2B expression in the LEC group 
was detected, although previous studies reported no MAT2B in normal rat livers and its 
increased expression in human cirrhosis and hepatoma [40]. Reductions in MAT1A 
mRNA levels in LEC rats appear compensated by increases in those of MAT2A, a 
common feature in hepatoma development [36]. Copper toxicity is known to produce a 
stress response that alters transcription of multiple genes involved in metal homeostasis 
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and protection against metal-induced damage [41]. This effect takes place primarily 
through interaction of metal transcription factor-1 (MTF-1) with metal response 
elements (MREs) located at the promoters of the target genes, but also through 
antioxidant response elements (AREs), as has been reported for metallothionein [41]. 
Although consensus sequences for both types of regulatory elements have been 
published [41 and references therein], no such elements are known to exist in the 
promoters of eukaryotic methionine metabolism related genes. In fact, a close 
inspection of MAT2B promoter sequence did not show exact matches for any of them. 
However, our data with H35 cells indicate a redox mechanism as responsible for the 
copper effects on MAT2B. Such a regulatory mechanism could involve an indirect 
effect through the modulation of redox-controlled transcription factors, for some of 
which the MAT2B promoter contains consensus-binding sites (i.e. NFκB) [42]. In fact, 
the prevention of copper effects exerted by BSO in this cell model together with the 
lack of such a protective effects for combinations including NAC, suggests the need for 
Cu(II) reduction to Cu(I) to obtain the expression decrease. This reaction could lead to 
the production of hydroxyl radicals that may react with target transcription factors, 
which in its oxidized form act on the MAT2B promoter. Moreover, the induced cell 
death observed in treatments combining copper and neocuproine, a preferred Cu(I) 
chelator, indicate reduction of copper (II) allowing production of neocuproine-Cu(I) 
complexes that are known to be toxic [43]. 
 The changes observed in mRNA correlate with those in protein levels for those 
enzymes for which antibodies are available. Metal stress regulation of MAT protein 
levels has been previously demonstrated in other organisms [44-46], thus suggesting it 
as a general regulatory mechanism for this family of highly homologous enzymes [47]. 
Effects in total MAT activity correlated with those in MAT1A transcripts and MATα1 
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subunits, rather than with a combination of the expression changes observed for 
MATα1 and MATα2. Such a result reflects the differences in specific activity and 
affinities shown by the three mammalian isoenzymes [1] (Figure 7B). Thus, reductions 
in MATα1 expression will decrease the amount of the isoenzymes with higher specific 
activity, which are the most abundant in normal liver [1], leading to a decrease in total 
activity. Indeed, MAT III decrease was confirmed by comparison of measurements 
made in the presence of DMSO and by gel filtration chromatography. The moderate 
increase in MAT II could not compensate for the decrease in MAT I/III function due to 
its lower specific activity. In contrast, at 60 µM methionine a slight increase in MAT 
activity (MAT I and II) could be measured, MAT II being under saturating conditions. 
Diminished expression of the regulatory subunit (MAT2β) reduced MAT II affinity for 
methionine to values close to those for MAT I and precluding their distinction [48]. 
These effects are also confirmed by measurement of the metabolite levels. Thus, the net 
decrease in MAT global activity correlates with the tendency of AdoMet levels to 
diminish in the LEC group (Figure 7A). On the other hand, the larger decrease in 
AdoHcy contrasts with the reduction in SAHH levels, indicating a higher rate of Hcy 
and adenosine production. Moreover, the lack of changes in Hcy levels detected 
indicates its consumption through trans-sulfuration and remethylation reactions, the 
increase in methionine concentration together with decreases in GSH levels indicating a 
preference for remethylation. Such an effect could be the result from the reduction in 
methionine consumption through AdoMet synthesis together with the modulation of 
inhibitory and stimulatory effects of this compound on BHMT and cystathione β 
synthase activities, respectively [1]. The small changes in MS expression could then be 
compensated by an increased Hcy remethylation through BHMT that guaranties 
recovery of methionine to sustain the AdoMet needs.  
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 Effects on activity could also rely either in copper catalyzed hydroxyl radical 
production and the corresponding alterations in the GSH/GSSG ratio or in binding to 
protein sulfhydryl groups [6]. Both processes could reduce MAT I/III catalysis through 
oxidation [37,49], including modification of cysteine 121 at the loop of access to the 
active site [49]. In the present study we have demonstrated inhibition by copper using 
the refolded MAT catalytic subunits, and the highest susceptibility of MATα1 subunits 
(those with C121) under low reducing conditions. In fact, the calculated IC50 values 
suggest the relevance of these effects for MATα1 in vivo, as was previously suggested 
for copper inhibition of SAHH [18], another of the enzymes showing decreased 
expression in LEC rats. Measurements of glutathione levels at these early phases of 
disease demonstrate that GSH concentrations are being reduced (∼30%), whereas GSSG 
levels tend to increase, and hence, a moderate oxidative stress is being reached in the 
tissue [50]. These conditions are known to modulate MAT I/III as it has been 
demonstrated in vivo [36] and in vitro [37]. 
 The decreased expression of MATα1 in LEC rats correlated with accumulation 
of tetramers (MAT I), in contrast with data obtained from cirrhotic samples and in 
galactosamine-treated animals [15]. Only certain degree of cross-reactivity with 
MATα2 could explain such behavior, since several factors, and among them oxidative 
stress, are known to favor MAT III accumulation [28,37]. Our data excluded disulfide 
production in MATα1, and could not relate the increased specific activity due DTT-
copper refolding to changes in dimer to tetramer association, but conformational 
alterations due to copper cannot be excluded as shown by the in vitro results presented. 
The need for chaperone assisted folding deduced from E. coli MAT binding to 
GroEL/GroES suggests that in vivo copper effects on folding of MAT catalytic subunits 
may occur through metallochaperones, a possibility that deserves additional studies.  
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 In summary, our results demonstrate an early alteration of methionine 
metabolism in LEC rats that might contribute to disease development. This effect is 
exerted through redox-mediated mechanisms at several levels that include protein 
expression and activity. Moreover, at these initial steps of disease the expected MATα1 
to MATα2 expression switch is already observed, but, in contrast, MAT2B expression 
drastically diminishes providing an additional effect on MAT activity due to a reduction 
of MAT II hetero-oligomers and the corresponding decrease in methionine affinity. 
Further effects of copper accumulation could also be expected on MAT folding as 
suggested by in vitro experiments, actions that could be exerted through redox-mediated 
mechanisms involving thiol-transferases and metallochaperones. 
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TABLES 
Table 1 
Measurements of metabolite levels in liver. The levels of metabolites of the 
methionine cycle, as well as of GSH and GSSG were measured in liver samples of 
control and LEC rats using mass spectrometry analysis. The results are expressed as the 
mean ± SD of the nmoles quantified per gram of tissue for each group. 
 
 LE 
(n=5) 
LEC 
(n=4) 
AdoMet (nmol/g)* 45.64 ± 13.25 35.15 ± 9.90 
AdoHcy (nmol/g) 32.52 ± 8.56 20.08 ± 5.41 
Hcy (nmol/g)* 1.51 ± 0.3** 1.55 ± 0.42** 
Methionine (nmol/g) 121.9 ± 7.35 171.9 ± 45.39 
GSH (µmol/g) 5.81 ± 0.27 3.96 ± 1.15 
GSSG (nmol/g)* 228.6 ± 34.07 270.05 ± 106.6 
GSH/GSSG* 25.90 ± 4.36 20.31 ± 13.67 
 *p > 0.05, non significant 
 **values at the detection limit 
 
 
 
 
 
 
 
 
 
Delgado et al. Copper accumulation and methionine cycle 30 
 
Table 2 
Activity measurements. MAT and BHMT activities were measured in liver cytosol as 
described under Materials and Methods. The data shown are the mean ± SD of 
measurements made in triplicate for every individual in each group. 
  LE 
(n=5) 
LEC 
(n=6) 
p 
60 µM Met 73.19 ± 6.49 85.73 ± 9.32 0.006 
60 µM Met + 10% 
DMSO 
272.91 ± 24.7 229.55 ± 60.26 0.027 
 
MAT 
(pmol/min/mg) 
5 mM Met 476.94 ± 162.23 339.9 ± 115.53 0.013 
 
BHMT 
(nmol/min/mg) 
  
0.533 ± 0.07 
 
0.517 ± 0.085 
 
0.334 
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FIGURE LEGENDS 
 Figure 1. Histological evaluation of the LEC rat livers. Paraffin embedded 
sections of LE (A through C) and LEC livers (D through F) of 9 weeks old rats were 
prepared and histologically characterized. For this purpose, hematoxilin/eosin (A, D) or 
metal specific staining techniques were used. The figure shows representative panels 
proving the presence of copper (B, E) and iron deposits (C,F) stained as black and dark 
brown spots, respectively. The horizontal bar represents 10 µm. 
 Figure 2. Analysis of the mRNA changes by real-time RT-PCR. Changes in 
mRNA levels for the enzymes involved in the hepatic methionine cycle were analyzed 
by real-time RT-PCR using the primers included in table 1 and SybrGreen dye. 
Experimental efficiencies for each transcript were calculated and used to determine the 
fold change according to the method of Pfaffl [22]. The histogram shows the fold 
change calculated against the control group using 18S rRNA as the reference. Statistical 
evaluation was performed using ratios for each individual vs 18S rRNA. * p<0.05  (LE 
group n=5, LEC group n=6).  
 Figure 3. Western blot analysis. Samples of cytosols (25 µg) from LE and 
LEC rats were loaded on SDS-PAGE gels for immunoblotting using either anti-MAT 
I/III, anti-BHMT, anti-SAHH or anti-α-tubulin antisera. The densitometric scans of the 
gels were corrected against the tubulin signal used as a control. The histogram presents 
the mean ± SD of the corrected data of samples for each group (LE n=5 and LEC n= 6). 
On the other hand, the insert shows blots of representative samples. 
 Figure 4. Gel filtration chromatography profiles of MAT elution. Cytosolic 
samples of LE and LEC rats (1 mg) were loaded on a Superose 12/10 HR column and 
fractions of the elution profile collected.  Samples of these fractions were used to 
measure total MAT activity at 5 mM methionine (), and for dot-blot analysis of 
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MATα1 protein localization (). The figure shows profiles of representative samples. 
The elution position of the markers is shown in the figure and was as follows: blue 
dextran (2000 kDa, 7.66 ml), apoferritin (443 kDa, 9.87 ml, a), β-amylase (200 kDa, 
11.97 ml, b), alcohol dehydrogenase (150 kDa, 12.81 ml, c), carbonic anhydrase (29 
kDa, 15.12 ml, d) and ATP (551 Da, 19.26 ml). 
 Figure 5. Effect of copper on MAT activity in vitro. Recombinant MATα1 
and MATα2 were obtained by refolding using the procedure of López-Vara et al. [30]. 
The effect of copper on their catalytic activities was then analyzed in the presence () 
or absence  () of reducing agents at 5 mM methionine. The figure shows results of a 
typical experiment carried out for MATα1 (panel A) and MATα2 (panel B). The results 
for each point are expressed as the mean ± SD of the triplicates obtained.  
 Figure 6. Changes of MAT2B expression in H35 cells. Hepatoma H35 cells 
were treated with copper (1 mM), NAC (5 mM), neocuproine (10 µM), BSO (1 mM) or 
the combination of these agents with the metal. NAC and BSO treatments were initiated 
8 hours before addition of the metal, whereas for neocuproine this period was 2 hours. 
In all the cases copper treatments lasted 24 hours before RNA isolation. The effects on 
MAT2B expression levels were then evaluated by real-time PCR. The figure shows the 
results (mean ± SD) of a typical experiment carried out in triplicate.  
 Figure 7. Copper regulation of the methionine cycle in early phases of 
Wilson’s disease. The figure summarizes the effects of copper on metabolite and 
enzyme levels as measured in this work in vivo. Arrows indicate the sign of the changes 
observed (red) and deduced (blue), and their thickness the extent of the variation. Panel 
A shows the changes in expression detected, as well as those in the metabolite levels of 
the cycle and in GSH and GSSG. The inhibitory and stimulatory effects of the copper-
induced alterations in the GSH/GSSG ratio and AdoMet levels on the activities of 
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several enzymes are also depicted. At these early phases of disease a reduction in 
expression for most of the enzymes of the cycle is observed that initiates a decrease in 
the flow through this pathway as shown by diminution in the metabolite levels and the 
slight increase in methionine. Additional actions on folding through metallochaperones 
and activities through redox modulation (on MAT I/III) and changes in AdoMet levels 
(on BHMT and CBS) can also be expected. Panel B shows in vivo results concerning 
MAT isoenzymes. Cooper induced reductions or increases in mRNA expression are 
indicated circled according to its sign. The large decrease in MAT 2B mRNA (80%) is 
expected to result in a reduction in the amount of regulatory subunit, and hence to a 
diminishment in that of the MAT II hetero-oligomers. In parallel, the decrease in 
MATα1 production is compensated by a similar increase in MATα2 subunits, both 
preferring tetramer association pattern under these conditions. However, these 
oligomeric assemblies are known to display intermediate affinities for methionine that 
together with their lower AdoMet synthesizing capacity and the modulation of MAT 
I/III though GSH/GSSG ratios renders reduced total activity. A reflect of these 
combined changes is the tendency of AdoMet levels to decrease in the LEC group. 
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Table 1 
Primer sequences used for Quantitative Real Time RT-PCR experiments. 
Appropriate primers were designed using the Program Primer Express 3.0 and the rat 
gene sequences available in the data bank with references: NC 005115 (MAT1A), NC 
005103 (MAT2A), NC 005109 (MAT2B), NC 005101 (BHMT), NC 005116 (MS) and 
NC 005102 (SAHH). Concentrations of the primers used in the amplifications appear in 
the right column. 
 forward reverse nM 
MAT 1A 5´-GCGAGAGCTACTAGAGGTTGTGAA-3´ 5´-AGATCCAAGTCCCTGACAATAACAC-3´ 300 
MAT 2A 5´-GGAGGGTTCTTGTTCAGGTCTCT-3´ 5´-GGAAAATGGAGATCGACAATGG-3´ 300 
MAT 2B 5´-GCAATTGCAGACGCCTTCA-3´ ´5´-CAGGGCTGTCAGTAATAGGTCGTA-3´ 300 
BHMT 5´-GGAGATCTACATGGCGTGTCT-3´ 5´-CGGCACCTGCTTTTACCAAA-3´ 300 
MS 5´ TCTGTGAAGACCTCATCTGGAACA 3´ 5´ TGAGAATGCTATACGGGT 3´ 300 
SAHH 5´ GGGCGGTGACCTTACTAACCTCAT 3´ 5´ TCGAAGACAGTCCTAGGCT 3´ 300 
18S 5´-CCAGTAAGTGCGGGTCATAAGC-3´ 5´-CCGATTGGATGGTTTAGTGAGG-3´ 100 
 
 
 
 
 
 
 
 
